Pemigatinib-d6

SL-9731

Pemigatinib-d₆, >98%

CAS No. : [2649492-49-7]

Related CAS No. : [1513857-77-6] of the unlabelled compound

Synonyms : INCB-054828-d₆

IUPAC Name : 3-(2,6-Difluoro-3,5-bis(methoxy-d₃)phenyl)-1-ethyl-8-(morpholinomethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Pemigatinib, which is an orally active, selective FGFR inhibitor. Pemigatinib is used to treat certain types of cancer that have specific gene alterations. Also, it has the potential for cholangiocarcinoma (bile duct cancer).

References : Arudra K. et al.: J. Cutan Pathol., 45(10), 786-790, 2018; Roskoski R. Jr. et al.: Pharmacol Res., 151, 104567, 2020; Krook M. A. et al.: Cold Spring Harb Mol Case Stud., 5(4), a004002, 2019.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.